1. R. Richard Wieland II
10 Ambrose Lane Home: (847) 382 – 1888
Barrington, IL 60010 Cell: (717) 487 – 5320
RRWieland@comcast.net www.LinkedIn.com/in/richardwieland
EXECUTIVE SUMMARY – LIFE SCIENCE CFO
A senior level financial executive with diverse business experience in the Life Science field, focused,
strategic and hands-on, functioning with a strong MBO approach. Direct experience in helping young
companies attract capital through private placements or IPO’s and working with the senior management
team in high-growth situations to build value for stockholders. Successful in raising capital through
private & public offerings (20 deals raising over $800M), M&A transactions (11 deals valued at $250M)
and developing partnership deals. Builds solid working relationships with Venture Capital, Private
Equity, Institutional Investors and Boards of Directors. International experience with Oak Technology
Group. Procter & Gamble financial management training program.
PROFESSIONAL EXPERIENCE
UNILIFE CORPORATION, York, PA 2010 – 2014
A NASDAQ traded $400M market cap medical device firm developing safety syringes and advanced
drug delivery devices.
Chief Financial Officer
• Reported to the CEO, responsible for Finance, Accounting and IT departments.
• Strong interaction with the Board of Directors and other outside financial advisors.
• Raised $100M through three equity financings & one equipment financing.
• Developed and maintained cash forecast and cash management programs.
• Led a successful Sarbanes-Oxley implementation.
• Coordinated a Global Tax Strategy initiative.
• Developed a company-wide integrated 5 year financial planning model.
• Implemented an SAP ERP system.
• Developed an Enterprise Risk Management program with the Board.
• Implemented a standard costing regime for various products.
CYTOCHROMA, Toronto, Canada and Bannockburn, IL 2008 – 2009
Privately-held, clinical-stage, biopharma firm developing drugs in the chronic kidney disease field.
Chief Financial Officer
• Reported to the CEO with responsibility for all financial affairs and Human Resources.
• Assisted in closing $45M Series C financing round with VC firms and foreign lender.
• Prepared IPO plan and S-1 for the Board, SEC counsel & Investment bankers.
• Frequent interaction with the Board of Directors and other outside advisors.
• Prepared and implemented a plan for Sarbanes-Oxley implementation.
• Developed a finance staff to function effectively as a public company.
• Worked with the Chief Sales Officer and Director of Business Development in deal making.
ADVANCED LIFE SCIENCES, Woodridge, IL 2004 – 2008
NASDAQ traded, clinical-stage, Biopharma firm developing drugs in the antibiotic field. Two Phase III
clinical development trials.
Chief Financial Officer
• Reported to the CEO, responsible for all financial affairs, M&A, IR and Human Resources.
• Assisted negotiations for in-licensing a Phase III compound from a top 10 pharma company.
• Interacted strongly with the Board of Directors and other outside advisors.
• Led IPO process in 2005 and two PIPE transactions in 2006 & 2007, totaling $70M.
• Implemented new accounting system & Sarbanes-Oxley program.

2. R. Richard Wieland II Page 2 of 3
INDEPENDENT CONSULTING 2002 – 2004
Engaged in interim consulting projects and increased technical skills, including Sarbanes-Oxley and
Green Belt certificate in Six Sigma.
MEDICHEM LIFE SCIENCES, Woodridge, IL 1999 – 2002
$22M NASDAQ traded firm providing chemistry services to biotechs & large Pharma.
Chief Financial Officer
• Reported to the CEO, responsible for finance, M&A, and Investor Relations.
• Acquired two technology companies in 2000 prior to IPO and helped integrate them.
• Worked closely with internal Venture Capital group.
• Led $40M IPO process.
• Company was acquired by deCode Genetics in 2002.
BIOGENEX LABORATORIES, San Ramon, CA 1996 – 1998
Privately-held company in cellular and molecular diagnostic systems in the histology / cytology arena.
Chief Financial Officer and Treasurer
• Reported to CEO, responsible for finance and accounting, IT, HR and Investor Relations.
• Raised first two rounds of $5M in VC funding, positioned for an IPO before market downturn.
OPTION CARE, INC., Bannockburn, IL 1993 – 1995
$250M market cap NASDAQ listed firm in the home healthcare market.
President and Chief Operating Officer
Member of the Board of Directors
• Inherited chaotic organization during period of fierce industry competition and price erosion.
Stabilized problem, recruited senior managers, and reorganized firm into four SBU’s.
• Acting CFO for majority of period, managed finance, accounting, legal, HR, IT, and IR.
• Created and managed six operating task forces that streamlined operations.
CANCER TREATMENT CENTERS, Arlington Heights, IL 1992 – 1993
Privately-held company with $130 revenue providing in-patient care to cancer patients.
President and Chief Operating Officer
• Reorganized firm into SBU’s, established profit plans and management accountability.
• Created 501(c) 3 Not-For-Profit foundation.
• Created a home care business unit for cancer patients.
• Led planning for VC investment and IPO.
FUJISAWA USA, Deerfield, IL 1984 – 1991
$250M subsidiary of Japan based $4B Fujisawa Pharmaceutical Company Ltd.
FUJISAWA, USA, Deerfield, IL 1990 – 1991
Chief Financial Officer and Treasurer
• Worked with outside accountants to finalize the valuation records, established financial reporting
system and implemented financial controls.
• Filed tax returns for merger entities and managed IRS audit.
• Assisted in arranging $250M long-term financing with Japanese bank syndicate.
• Relocated $40M joint venture from Philadelphia to Chicago.
• Traveled to Japan to present the US’s first strategic plan.

3. R. Richard Wieland II Page 3 of 3
LYPHOMED, INC. Deerfield, IL 1984 – 1990
$250M NASDAQ listed pharma company, acquired by Fujisawa in 1990
Chief Financial Officer
• Responsible for finance, accounting, treasury, tax, IT, internal audit, legal, IR, and planning.
• Managed $43M equity and $100M debt offerings.
• Developed planning function and model that improved profitability across product lines.
• Managed successfully in a high-growth environment.
• Coordinated due diligence, acquisition and integration of two companies, doubling sales.
• Developed a strong IR program and managed 15 analysts and 30 institutional investors.
• Implemented a captive insurance program in Bermuda saving the company $1M.
• Assumed general manager responsibility for sales & marketing in Canada.
• Coordinated $20M manufacturing project in Puerto Rico to annually save $10M in taxes.
OAK TECHNOLOGY, Crystal Lake, IL
$350M subsidiary of Oak Industries, a Fortune 500 manufacturer of electronic components, valves and
printed circuit boards. Twenty two entities (50% international)
VP-Controller
ACOUSTIFLEX CORPORATION, Oak Brook, IL
$7M manufacturer of acoustical ceiling products sold nationally through distributors.
Chief Financial Officer
PROCTER AND GAMBLE, Cincinnati, OH
A Fortune 25 global consumer products company
Financial Management Training Program (5 separate assignments)
EDUCATION
MBA, Washington University, St. Louis, MO
BA, Accounting and Economics, Monmouth College, Monmouth, IL
OTHER AFFILIATIONS AND QUALIFICATIONS
Monmouth College – Alumni Board (served 4 years)
President, Wieland Family Foundation (Charity for Disadvantaged Children)
President, ARJCO Foundation (Charity for Higher Education)
Former Board Member of Option Care Inc., a NASDAQ home healthcare company
U.S. Army Reserve, Officer, Signal Corps.